Echosens Sustainability Profile
Echosens, a pioneering company in the field of non-invasive liver diagnostics, is headquartered in France and operates across major regions including Europe, North America, and Asia. Founded in 2008, Echosens has established itself as a leader in the medical technology industry, particularly in the development of innovative solutions for liver health assessment. The company’s flagship product, FibroScan®, utilises advanced elastography technology to provide accurate measurements of liver stiffness and fat content, setting it apart from traditional biopsy methods. Echosens has achieved significant milestones, including regulatory approvals and widespread adoption in clinical settings, reinforcing its market position as a trusted provider of liver diagnostic tools. With a commitment to improving patient outcomes, Echosens continues to drive advancements in liver disease management.
DitchCarbon Score
How does Echosens's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Echosens's score of 56 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Echosens's reported carbon emissions
Echosens, headquartered in France, has set ambitious climate commitments to address its carbon emissions. Although specific emissions data is not available, the company has established significant reduction targets through the Science Based Targets initiative (SBTi). Echosens commits to reducing its Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 46% by 2030, using 2019 as the base year. Furthermore, the company aims for a substantial reduction of 90% in Scope 1, Scope 2, and Scope 3 emissions by 2050, also from a 2019 baseline. These targets align with the 1.5°C climate goal, demonstrating Echosens's commitment to sustainable practices within the healthcare sector. The company is actively working to measure and reduce its Scope 3 emissions, which encompass indirect emissions from its value chain. Echosens's initiatives reflect a proactive approach to climate action, positioning it as a responsible player in the healthcare technology industry.
How Carbon Intensive is Echosens's Industry?
How Carbon Intensive is Echosens's Location?
Echosens's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Echosens has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
